Discussion: ‘Factor V Leiden mutation’ by Kjellberg et al




In the roundtable that follows, clinicians discuss a study published in this issue of the Journal in light of its methodology, relevance to practice, and implications for future research. Article discussed:


Kjellberg U, van Rooijen M, Bremme K, Hellgren M. Factor V Leiden mutation and pregnancy-related complications. Am J Obstet Gynecol 2010;203:469.e1-8.


Discussion Questions




  • ■

    Why is factor V Leiden (FVL) important in pregnancy?


  • ■

    What was the study’s hypothesis?


  • ■

    What were the details of the study design?


  • ■

    What information was provided by the tables?


  • ■

    Which endpoints were likely to be truly associated with FVL?


  • ■

    How did the findings correspond with results from previous studies?


  • ■

    How might the results change your practice approach?


Only gold members can continue reading. Log In or Register to continue

Related posts:

  1. Inadvertent rupture of benign cystic teratoma does not impair future fertility
  2. Factor V Leiden mutation and pregnancy-related complications
  3. Using the Brink score to predict postpartum anal incontinence
  4. Pelvic magnetic resonance imaging for assessment of the efficacy of the Prolift system for pelvic organ prolapse

Stay updated, free articles. Join our Telegram channel
Tags:
Jun 21, 2017 | Posted by in GYNECOLOGY | Comments Off on Discussion: ‘Factor V Leiden mutation’ by Kjellberg et al

Full access? Get Clinical Tree
Get Clinical Tree app for offline access